Ampio Pharmaceuticals
AMPE
#10613
Rank
$0 M
Marketcap
$0.005200
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Ampio Pharmaceuticals (AMPE)

Earnings in 2023 (TTM): -$8.64 Million USD

According to Ampio Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2022 earnings that were of -$16.34 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ampio Pharmaceuticals from 2007 to 2023

Annual earnings

Year Earnings Change
2023 -$8.64 Million-47.14%
2022 -$16.34 Million-4.36%
2021 -$17.08 Million7.42%
2020 -$15.9 Million16.62%
2019 -$13.63 Million-140.1%
2018 $33.98 M-165.49%
2017 -$51.9 Million170.77%
2016 -$19.17 Million-30.16%
2015 -$27.45 Million-29.73%
2014 -$39.05 Million59.2%
2013 -$24.53 Million111.58%
2012 -$11.6 Million-36.57%
2011 -$18.28 Million127.2%
2010 -$8.05 Million758.38%
2009 -$0.94 Million3105.94%
2008 -$0.03 Million0.79%
2007 -$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-$23.25 Million 169.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-375,401.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-$79.39 Million 819.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
$0.12 B-1,512.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$8.13 B-94,377.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$5.14 B-59,704.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$11.85 B-137,403.06%๐Ÿ‡บ๐Ÿ‡ธ USA